Assignee
MANNKIND CORP
US·215 granted patents·98 pending applications·3,688 citations·filing 1998–2025
Top patents by PatentIndex Score
313 records- 0199US7820676B2Diketopiperazine salts for drug delivery and related methodsMANNKIND CORP·Filed 2005·Granted Oct 26, 2010·81 cites·13 claims
- 0298US9772216B2Powder dispensing and sensing apparatus and methodsMANNKIND CORP·Filed 2014·Granted Sep 26, 2017·43 cites·14 claims
- 0398US8778403B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2013·Granted Jul 15, 2014·48 cites·20 claims
- 0498US8039431B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2007·Granted Oct 18, 2011·58 cites·16 claims
- 0598US7833550B2Dry powder formulations of antihistamine for nasal administrationMANNKIND CORP·Filed 2007·Granted Nov 16, 2010·40 cites·13 claims
- 0698US7799344B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2006·Granted Sep 21, 2010·93 cites·18 claims
- 0798US6652885B2Purification and stabilization of peptide and protein pharmaceutical agentsMANNKIND CORP·Filed 2002·Granted Nov 25, 2003·171 cites·6 claims
- 0897US8372804B2Delivery of active agentsMANNKIND CORP·Filed 2008·Granted Feb 12, 2013·60 cites·21 claims
- 0997US7943178B2Methods and compositions for delivering peptidesMANNKIND CORP·Filed 2009·Granted May 17, 2011·60 cites·23 claims
- 1097US7836922B2Powder dispenser modules and powder dispensing methodsMANNKIND CORP·Filed 2006·Granted Nov 23, 2010·32 cites·21 claims
- 1197US7803404B2Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfacesMANNKIND CORP·Filed 2006·Granted Sep 28, 2010·76 cites·25 claims
- 1297US7709639B2Catalysis of diketopiperazine synthesisMANNKIND CORP·Filed 2005·Granted May 4, 2010·68 cites·24 claims
- 1397US7648960B2Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticlesMANNKIND CORP·Filed 2003·Granted Jan 19, 2010·72 cites·11 claims
- 1497US6861234B1Method of epitope discoveryMANNKIND CORP·Filed 2000·Granted Mar 1, 2005·111 cites·19 claims
- 1596USD1011511SFluid delivery deviceMANNKIND CORP·Filed 2021·Granted Jan 16, 2024·3 cites·1 claims
- 1696US10870628B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino esterMANNKIND CORP·Filed 2020·Granted Dec 22, 2020·3 cites·20 claims
- 1796US10620034B2Powder dispensing and sensing apparatus and methods for simultaneous filling of cartridgesMANNKIND CORP·Filed 2017·Granted Apr 14, 2020·10 cites·20 claims
- 1896US8377869B2Method of preventing adverse effects by GLP-1MANNKIND CORP·Filed 2008·Granted Feb 19, 2013·57 cites·20 claims
- 1996US7950423B2Powder transport systems and methodsMANNKIND CORP·Filed 2006·Granted May 31, 2011·23 cites·29 claims
- 2096US7794754B2Methods for fine powder formationMANNKIND CORP·Filed 2006·Granted Sep 14, 2010·39 cites·5 claims
- 2196US7364729B2Method of inducing a CTL responseMANNKIND CORP·Filed 2005·Granted Apr 29, 2008·28 cites·16 claims
- 2295US11345668B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino esterMANNKIND CORP·Filed 2020·Granted May 31, 2022·2 cites·20 claims
- 2395US10577331B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediateMANNKIND CORP·Filed 2018·Granted Mar 3, 2020·5 cites·17 claims
- 2495US9944609B2Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2015·Granted Apr 17, 2018·6 cites·20 claims
- 2595US9187433B2Formation of N-protected 3,6-bis-(4-aminobutyl) -2, 5-diketopiperazine through a cyclic α-N-protected active amino ester intermediateMANNKIND CORP·Filed 2015·Granted Nov 17, 2015·8 cites·20 claims
- 2695US8962836B2Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2014·Granted Feb 24, 2015·9 cites·14 claims
- 2795US7958916B2Powder dispensing and sensing apparatus and methodsMANNKIND CORP·Filed 2006·Granted Jun 14, 2011·20 cites·53 claims
- 2895USD605752SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 8, 2009·63 cites·1 claims
- 2995US6977074B2Method of inducing a CTL responseMANNKIND CORP·Filed 2001·Granted Dec 20, 2005·89 cites·32 claims
- 3095US6709844B1Avoidance of undesirable replication intermediates in plasmid propagationMANNKIND CORP·Filed 2000·Granted Mar 23, 2004·75 cites·22 claims
- 3194US12049453B2Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino esterMANNKIND CORP·Filed 2022·Granted Jul 30, 2024·1 cites·20 claims
- 3294US10500159B2Apparatus and method for cryogranulating a pharmaceutical compositionMANNKIND CORP·Filed 2018·Granted Dec 10, 2019·6 cites·15 claims
- 3394US8909487B2Apparatus, system and method for measuring resistance of an inhalerMANNKIND CORP·Filed 2013·Granted Dec 9, 2014·43 cites·15 claims
- 3494USD635241SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Mar 29, 2011·56 cites·1 claims
- 3594USD629887SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·59 cites·1 claims
- 3694USD629886SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·59 cites·1 claims
- 3794USD629888SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·54 cites·1 claims
- 3894USD629506SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Dec 21, 2010·53 cites·1 claims
- 3994USD614760SDry powder inhalerMANNKIND CORP·Filed 2009·Granted Apr 27, 2010·59 cites·1 claims
- 4094USD613849SCartridge for a dry powder inhalerMANNKIND CORP·Filed 2009·Granted Apr 13, 2010·49 cites·1 claims
- 4194USD604833SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Nov 24, 2009·54 cites·1 claims
- 4294USD597657SDry powder inhalerMANNKIND CORP·Filed 2008·Granted Aug 4, 2009·57 cites·1 claims
- 4394US7511119B2PRAME peptide analoguesMANNKIND CORP·Filed 2006·Granted Mar 31, 2009·12 cites·26 claims
- 4494US7305986B1Unit dose capsules for use in a dry powder inhalerMANNKIND CORP·Filed 2000·Granted Dec 11, 2007·175 cites·5 claims
- 4594US7278843B2Methods for fine powder formationMANNKIND CORP·Filed 2002·Granted Oct 9, 2007·39 cites·3 claims
- 4694US6991779B2Compositions for treatment or prevention of bioterrorismMANNKIND CORP·Filed 2003·Granted Jan 31, 2006·60 cites·15 claims
- 4794US2026042739A1Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazineMANNKIND CORP·Filed 2025·Application pending·0 cites
- 4894US2026027054A1Apparatus and method for cryogranulating a pharmaceutical compositionMANNKIND CORP·Filed 2025·Application pending·0 cites
- 4993US11479535B2Methods for the synthesis of activated ethylfumarates and their use as intermediatesMANNKIND CORP·Filed 2020·Granted Oct 25, 2022·2 cites·6 claims
- 5093US11185645B2Dry powder inhaler and system for drug deliveryMANNKIND CORP·Filed 2018·Granted Nov 30, 2021·2 cites·20 claims
Showing the top 50 of 313 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →